N-[(E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,5S,7R,8S,9R,12E,14E,17S,19R)-4,17-Dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxododec-1-enyl]-N-methylformamide

Term ID

CHEBI:182751

Synonyms

N-[(E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,5S,7R,8S,9R,12E,14E,17S,19R)-4,17-dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxododec-1-enyl]-N-methylormamide

Definition

References

Chemspider:10273414

Ontology

ChEBI ( EBI )

Relationships

is a type of: diterpene lactone

diterpene lactone Show first 5 Terms

Phenotype

Phenotype resulting from N-[(E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,5S,7R,8S,9R,12E,14E,17S,19R)-4,17-Dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxododec-1-enyl]-N-methylformamide

Phenotype where environments contain N-[(E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,5S,7R,8S,9R,12E,14E,17S,19R)-4,17-Dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxododec-1-enyl]-N-methylformamide

Phenotype modified by environments containing N-[(E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,5S,7R,8S,9R,12E,14E,17S,19R)-4,17-Dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxododec-1-enyl]-N-methylformamide

Human Disease / Model Data

Citations